Annette Feuchtinger Selected Research

Carcinogenesis

12/2021

Patterns of Carbon-Bound Exogenous Compounds in Patients with Lung Cancer and Association with Disease Pathophysiology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annette Feuchtinger Research Topics

Disease

37	Neoplasms (Cancer) 12/2023 - 12/2011
14	Obesity 05/2024 - 10/2018
9	Type 2 Diabetes Mellitus (MODY) 11/2023 - 01/2016
9	Body Weight (Weight, Body) 11/2023 - 11/2015
8	Adenocarcinoma 01/2022 - 08/2012
6	Stomach Neoplasms (Stomach Cancer) 01/2024 - 12/2011
6	Insulin Resistance 10/2022 - 01/2016
5	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2015
4	Atherosclerosis 03/2024 - 01/2020
4	Adenoma (Adenomas) 01/2023 - 04/2017
4	Fibrosis (Cirrhosis) 01/2021 - 11/2013
3	Metabolic Diseases (Metabolic Disease) 05/2024 - 01/2021
3	Lung Neoplasms (Lung Cancer) 12/2023 - 12/2017
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 12/2020
3	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2017
3	Fatty Liver 01/2021 - 01/2017
3	Hyperglycemia 10/2020 - 01/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 11/2014
2	Weight Loss (Weight Reduction) 11/2023 - 01/2019
2	Dyslipidemias (Dyslipidemia) 01/2023 - 10/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2017
2	Residual Neoplasm 01/2022 - 12/2012
2	Inflammation (Inflammations) 01/2021 - 05/2019
2	Hyperaldosteronism (Conn Syndrome) 01/2020 - 04/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 08/2013
2	Hypertension (High Blood Pressure) 01/2020 - 04/2017
2	Adrenocortical Carcinoma 10/2019 - 01/2019
2	Myocardial Infarction 04/2018 - 03/2014
2	Infarction (Infarctions) 04/2018 - 03/2014
2	Cicatrix (Scar) 04/2018 - 03/2014
2	Breast Neoplasms (Breast Cancer) 07/2016 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016 - 01/2015
2	Hepatocellular Carcinoma (Hepatoma) 10/2015 - 11/2013
2	Colorectal Neoplasms (Colorectal Cancer) 03/2015 - 05/2013
2	Sarcoma (Soft Tissue Sarcoma) 11/2014 - 01/2013
2	Lymphoma (Lymphomas) 01/2013 - 10/2012
2	Uveitis 05/2011 - 10/2010
1	Adenocarcinoma of Lung 12/2023
1	Infections 11/2023
1	Drug-Related Side Effects and Adverse Reactions 07/2023
1	Hepatolenticular Degeneration (Wilson's Disease) 07/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023

Drug/Important Bio-Agent (IBA)

14	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 12/2012
11	Proteins (Proteins, Gene)FDA Link 11/2023 - 10/2010
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2015
6	Peptides (Polypeptides)IBA 05/2024 - 01/2019
4	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2024 - 01/2019
3	Trastuzumab (Herceptin)FDA Link 01/2024 - 01/2021
3	gastric inhibitory polypeptide receptorIBA 11/2023 - 01/2021
3	Insulin (Novolin)FDA Link 10/2022 - 01/2016
3	LipidsIBA 12/2021 - 01/2017
3	AldosteroneIBA 01/2020 - 04/2017
3	Sorafenib (BAY 43-9006)FDA Link 10/2015 - 01/2013
2	human ERBB2 proteinIBA 01/2024 - 07/2016
2	CarbonIBA 12/2023 - 12/2021
2	AminesIBA 12/2023 - 12/2021
2	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 12/2023 - 12/2021
2	NitrosaminesIBA 12/2023 - 12/2021
2	SootIBA 11/2023 - 12/2021
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2023 - 04/2017
2	ParaffinIBA 01/2023 - 01/2020
2	Formaldehyde (Formol)FDA Link 01/2023 - 01/2020
2	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 01/2023 - 04/2017
2	CytokinesIBA 01/2022 - 12/2017
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 01/2016
2	Polysaccharides (Glycans)IBA 12/2021 - 09/2017
2	Phosphotransferases (Kinase)IBA 06/2021 - 12/2017
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2021
2	Contrast MediaIBA 01/2021 - 03/2014
2	IntegrinsIBA 01/2021 - 01/2017
2	GlucocorticoidsIBA 01/2021 - 04/2017
2	gadofluorine PIBA 01/2020 - 04/2018
2	SteroidsIBA 10/2019 - 04/2017
2	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2019 - 10/2012
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2018 - 10/2018
2	Gadolinium DTPA (Magnevist)FDA Link 04/2018 - 03/2014
2	ErbB Receptors (EGF Receptor)IBA 09/2017 - 05/2013
2	BezafibrateIBA 01/2017 - 01/2016
2	Cathepsin BIBA 07/2016 - 01/2016
2	Plasminogen Activator Inhibitor 1IBA 07/2016 - 01/2016
2	Urokinase Plasminogen Activator ReceptorsIBA 07/2016 - 01/2016
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2016 - 01/2016
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016 - 11/2014
2	CollagenIBA 01/2015 - 11/2013
2	Retinaldehyde (Retinal)IBA 07/2014 - 05/2011
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2024
1	Glucagon-Like Peptide-1 ReceptorIBA 05/2024
1	ProteomeIBA 03/2024
1	Nonesterified Fatty Acids (NEFA)IBA 03/2024
1	oxidized low density lipoproteinIBA 03/2024
1	Carbon Nanotubes (Carbon Nanotube)IBA 11/2023
1	methanobactinIBA 07/2023
1	CopperIBA 07/2023

Therapy/Procedure

26	Therapeutics 10/2022 - 10/2012
9	Lasers (Laser) 12/2023 - 12/2011
6	Cyclotrons 12/2023 - 01/2018
4	Drug Therapy (Chemotherapy) 01/2023 - 01/2013
3	Aftercare (After-Treatment) 01/2022 - 01/2013
2	Neoadjuvant Therapy 01/2022 - 01/2022
1	Drug Substitution 07/2023